AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ESOMEPRAZOLE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CP-ESOMEPRAZOLE POWDER/INJECTABLE; INJECTION | 2026/16.7/7378 | COSPHARM INVESTMENTS PVT LTD | active | 31 Mar 2031 |
| ESGEAR 20 TABLET; ORAL | 2025/16.7/7172 | PHARMAQON, | active | 18 Nov 2030 |
| ESGEAR 40 TABLET; ORAL | 2025/16.7/7173 | PHARMAQON, | active | 18 Nov 2030 |
| MAGPRAZ 40 TABLET, COATED; ORAL | 2023/16.7/6531 | MYLAN LABORATORIES LIMITED [OTL] | active | 7 Dec 2028 |
| MAGPRAZ 20 TABLET, COATED; ORAL | 2023/16.7/6530 | MYLAN LABORATORIES LIMITED [OTL] | active | 7 Dec 2028 |
ESOMEPRAZOLE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing ESOMEPRAZOLE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ESOMEPRAZOLE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.